Are all Type I human interferons equivalent?

被引:83
作者
Foster, GR
Finter, NB
机构
[1] St Marys Hosp, Liver Unit, Imperial Coll Sch Med, London W2 1PG, England
[2] Tideswell, Sevenoaks, Kent, England
关键词
immunomodulation; interferon; subtypes;
D O I
10.1046/j.1365-2893.1998.00103.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Type I interferons are a family of closely related cytokines that have antiviral and immunostimulatory properties. There has been prolonged debate regarding the different interferon-alpha subtypes: with some authorities suggest that the different interferons have essentially similar properties but others argue that there are significant differences between them. Recent work has shown that the various interferon-alpha subtypes can interact with the interferon receptor components in different ways and can activate a number of different signalling pathways. Recent studies on the immunomodulatory properties of the Type I interferons indicate that there are profound differences between the subtypes. The clinical significance of all these differences remains to be determined.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 61 条
[1]   NOMENCLATURE OF THE HUMAN INTERFERON PROTEINS [J].
ALLEN, G ;
DIAZ, MO ;
FINTER, NB ;
ADOLF, GR ;
DOLY, J ;
LUNDGREN, E ;
PESTKA, S ;
ROBERTS, RM ;
TESTA, D ;
WIETZERBIN, J .
JOURNAL OF INTERFERON RESEARCH, 1994, 14 (04) :223-226
[2]   NEUTRALIZING ANTIBODIES TO INTERFERON-ALPHA - RELATIVE FREQUENCY IN PATIENTS TREATED WITH DIFFERENT INTERFERON PREPARATIONS [J].
ANTONELLI, G ;
CURRENTI, M ;
TURRIZIANI, O ;
DIANZANI, F .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :882-885
[3]   CLINICAL-SIGNIFICANCE OF RECOMBINANT INTERFERON-ALPHA(2) NEUTRALIZING ANTIBODIES IN HEPATITIS PATIENTS [J].
ANTONELLI, G ;
GIANNELLI, G ;
PISTELLO, M ;
MAGGI, F ;
VATTERONI, L ;
CURRENTI, M ;
DELVECCHIO, S ;
ROFFI, L ;
PASTORE, G ;
DIANZANI, F .
JOURNAL OF INTERFERON RESEARCH, 1994, 14 (04) :211-213
[4]  
ANTONELLI G, 1993, ARCH VIROL, P271
[5]  
BEASLEY RP, 1981, LANCET, V2, P1129
[6]   ANTIBODIES DEVELOPING AGAINST A SINGLE RECOMBINANT INTERFERON PROTEIN MAY NEUTRALIZE MANY OTHER INTERFERON-ALPHA SUBTYPES [J].
BRAND, CM ;
LEADBEATER, L ;
BELLATI, G ;
MAROTTA, F ;
IDEO, G .
JOURNAL OF INTERFERON RESEARCH, 1993, 13 (02) :121-125
[7]   REQUIREMENT FOR MAP KINASE (ERK2) ACTIVITY IN INTERFERON-ALPHA-STIMULATED AND INTERFERON-BETA-STIMULATED GENE-EXPRESSION THROUGH STAT PROTEINS [J].
DAVID, M ;
PETRICOIN, E ;
BENJAMIN, C ;
PINE, R ;
WEBER, MJ ;
LARNER, AC .
SCIENCE, 1995, 269 (5231) :1721-1723
[8]   Comparative effects of interferon-consensus 1, interferon-alpha(2a), and interferon-beta(1b), on HLA expression and lymphoproliferation: A preclinical model for treatment of multiple sclerosis [J].
DhibJalbut, S ;
Jiang, H ;
Xia, QA ;
Blatt, L ;
Johnson, KP ;
Hilt, D .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (03) :195-200
[9]  
Evinger M, 1980, Ann N Y Acad Sci, V350, P399, DOI 10.1111/j.1749-6632.1980.tb20641.x
[10]   Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Diodati, G ;
Tremolada, F ;
Nevens, F ;
Almasio, P ;
Solinas, A ;
Brouwer, JT ;
Thomas, H ;
Realdi, G ;
Corrocher, R ;
Schalm, SW ;
Bhalla, A ;
Casarin, C ;
Bonetti, P ;
Basho, J ;
Fuschi, P ;
Tocco, A ;
Mura, D .
JOURNAL OF HEPATOLOGY, 1997, 27 (01) :201-205